末梢血管デバイスの市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

末梢血管デバイス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の末梢血管デバイス市場規模は、2025年から2030年にかけてCAGR 5.8％を記録し、2030年には148億米ドルに達する見込みです。

市場成長を促進する要因は、末梢動脈疾患（パッド）の有病率の増加、臨床試験・研究の増加、技術の進歩、政府の取り組みです。製薬会社や医療機器メーカーは、末梢血管疾患PVDの革新的な解決策を探るため、臨床試験に資金を提供するようになってきています。この動向は製品開発サイクルを加速させ、業界の利害関係者と学術機関の協力を促しています。

より多くの研究が開始されるにつれて、生成されたデータはこれらの機器の性能と有効性の改善に大きく役立ちます。さらに、臨床試験の増加に対する規制当局の支援がこうした取り組みを後押しし、市場における先進的なソリューションの開発が促進されると予想されます。例えば、2024年6月、AVS社はFDAから、同社の拍動性血管内結石破砕（PIL）システムの臨床試験を実施するための治験機器適用除外（IDE）を取得しました。この臨床試験は、末梢動脈疾患患者におけるPILシステムの安全性と有効性を評価するものです。AVS社は、石灰化した血管状態に苦しむ患者に対する侵襲性の低い治療法の開発において重要な一歩を踏み出し、複数の施設でこの試験を開始する予定です。このような市場プレイヤーの努力は、研究開発環境の開拓と相まって、予測期間中の市場成長を促進すると予想されます。

さらに、末梢血管デバイス市場の競合情勢が進化していることで、パートナーシップ、事業拡大、合意、買収など、世界のヘルスケアセクターへのこれらの先進的なデバイスの提供や利用可能性を大幅に向上させる市場プレイヤーのイニシアチブがいくつか生まれています。例えば、2024年6月、ボストン・サイエンティフィック社は、頸動脈疾患の革新的なソリューションに特化したシルクロード・メディカル社を買収することで合意したと発表しました。この買収額は約11億米ドルで、ボストン・サイエンティフィックの血管インターベンションにおけるポートフォリオを強化し、成長する頸動脈市場でのプレゼンスを拡大することを目的としています。このような市場参入企業による製品提供の拡大への取り組みは、これらのデバイスの入手可能性の増大と相まって、予測期間中の市場成長を促進すると予想されます。

末梢血管デバイス市場のレポートハイライト

• タイプ別では、末梢ステント分野が2024年に約21.7%の最大シェアを占めました。資金援助や承認という形で政府の支援が高まっていることが、技術的に先進的な末梢ステントの開発をメーカーに促しています。
• 用途別では、末梢動脈疾患（PAD）分野が2024年に45.3％近くの最大シェアを占めました。末梢動脈疾患の有病率の上昇と政府の取り組みが、このセグメントの成長を牽引しています。
• 最終用途別では、病院セグメントが2024年に約64.4％の最大シェアを占めました。病院は、経皮経硬動脈バイパス（PTAB）を含む高度な医療処置の実施に極めて重要です。
• 北米は、2024年に38.9％のシェアを獲得し、末梢血管デバイスを支配しました。末梢血管デバイス市場は、末梢動脈疾患（PAD）の罹患率の増加、老人人口の増加、医療技術の急速な進歩など、いくつかの要因によって安定した成長を示しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 末梢血管デバイス市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• 末梢血管デバイス市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 末梢血管デバイス市場：タイプ推定・動向分析

• 末梢血管デバイス市場：タイプダッシュボード
• 末梢血管デバイス市場：タイプ変動分析
• 末梢血管デバイス市場規模と予測および動向分析、タイプ別、2018～2030年
• 末梢ステント
• PTAバルーン
• カテーテル
• 血管内動脈瘤修復ステントグラフト
• プラーク修正装置
• 周辺機器アクセサリ
• 下大静脈フィルター
  • 永久フィルター
  • 取得可能なフィルター
• 血行動態血流調節装置
  • 慢性完全閉塞デバイス
  • 塞栓保護デバイス

第5章 末梢血管デバイス市場：用途の推定・動向分析

• 末梢血管デバイス市場：用途ダッシュボード
• 末梢血管デバイス市場：用途の変動分析
• 末梢血管デバイス市場規模と予測および動向分析、用途別、2018～2030年
• 末梢動脈疾患（PAD）
• 動脈瘤
• 静脈疾患
• その他

第6章 末梢血管デバイス市場：最終用途の推定・動向分析

• 末梢血管デバイス市場：最終用途ダッシュボード
• 末梢血管デバイス市場：最終用途変動分析
• 末梢血管デバイス市場規模と予測および動向分析、最終用途別、2018～2030年
• 病院
• 外来手術センター
• その他

第7章 末梢血管デバイス市場：国、タイプ、用途、最終用途、地域別の地域推定・動向分析

• 地域ダッシュボード
• 市場規模と予測動向分析、2018年から2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要販売代理店およびチャネルパートナーのリスト
  • Key customers
  • Key company market share analysis, 2023
  • Abbott
  • Koninklijke Philips NV
  • Edward Lifesciences Corporation
  • Medtronic
  • Teleflex Incorporated
  • Cook Group
  • Cordis
  • Boston Scientific Corporation
  • WL Gore &Associates, Inc.
  • Biotronik
  • BD
  • Terumo Corporation

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviation
• Table 3 Global peripheral vascular devices market, by type 2018 - 2030 (USD Million)
• Table 4 Global peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 5 Global peripheral vascular devices market, by end-use, 2018 - 2030
• Table 6 Global peripheral vascular devices market, by region, 2018 - 2030 (USD Million)
• Table 7 North America peripheral vascular devices market, by country, 2018 - 2030 (USD Million)
• Table 8 North America peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 9 North America peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 10 North America peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 11 U.S. peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 12 U.S. peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 13 U.S. peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 14 Canada peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 15 Canada peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 16 Canada peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 17 Mexico peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 18 Mexico peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 19 Mexico peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 20 Europe peripheral vascular devices market, by country, 2018 - 2030 (USD Million)
• Table 21 Europe peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 22 Europe peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 23 Europe peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 24 U.K. peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 25 U.K. peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 26 U.K. peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 27 Germany peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 28 Germany peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 29 Germany peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 30 France peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 31 France peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 32 France peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 33 Italy peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 34 Italy peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 35 Italy peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 36 Spain peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 37 Spain peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 38 Spain peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 39 Denmark peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 40 Denmark peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 41 Denmark peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 42 Sweden peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 43 Sweden peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 44 Sweden peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 45 Norway peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 46 Norway peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 47 Norway peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific peripheral vascular devices market, by country, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 51 Asia Pacific peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 52 Japan peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 53 Japan peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 54 Japan peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 55 China peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 56 China peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 57 China peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 58 India peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 59 India peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 60 India peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 61 Australia peripheral vascular devices market, by country, 2018 - 2030 (USD Million)
• Table 62 Australia peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 63 Australia peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 64 Australia peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 65 Thailand peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 67 Thailand peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 68 Thailand peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 69 South Korea peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 70 South Korea peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 71 South Korea peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 72 Latin America peripheral vascular devices market, by country, 2018 - 2030 (USD Million)
• Table 73 Latin America peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 74 Latin America peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 75 Latin America peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 76 Brazil peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 77 Brazil peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 78 Brazil peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 79 Argentina peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 80 Argentina peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 81 Argentina peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 82 MEA peripheral vascular devices market, by country, 2018 - 2030 (USD Million)
• Table 83 MEA peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 84 MEA peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 85 MEA peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 86 South Africa peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 87 South Africa peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 88 South Africa peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 89 Saudi Arabia peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 90 Saudi Arabia peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 91 Saudi Arabia peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 92 UAE peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 93 UAE peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 94 UAE peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 95 Kuwait peripheral vascular devices market, by type, 2018 - 2030 (USD Million)
• Table 96 Kuwait peripheral vascular devices market, by application, 2018 - 2030 (USD Million)
• Table 97 Kuwait peripheral vascular devices market, by end-use, 2018 - 2030 (USD Million)
• Table 98 Participant's overview
• Table 99 Financial performance
• Table 100 Key companies undergoing expansions
• Table 101 Key companies undergoing acquisitions
• Table 102 Key companies undergoing collaborations
• Table 103 Key companies launching new product types
• Table 104 Key companies undergoing partnerships
• Table 105 Key companies undertaking other strategies

List of Figures

• Fig. 1 Peripheral vascular devices market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Market formulation & validation
• Fig. 7 Market snapshot
• Fig. 8 Segment snapshot - I
• Fig. 9 Segment snapshot -II
• Fig. 10 Competitive landscape
• Fig. 11 Peripheral vascular devices market dynamics
• Fig. 12 Peripheral vascular devices market: PORTER's analysis
• Fig. 13 Peripheral vascular devices market: PESTEL analysis
• Fig. 14 Peripheral vascular devices market: Type dashboard
• Fig. 15 Peripheral vascular devices market Type movement analysis
• Fig. 16 Global peripheral stents market, 2018 - 2030 (USD Million)
• Fig. 17 Iliac artery stents market, 2018 - 2030 (USD Million)
• Fig. 18 Femoral artery stents market, 2018 - 2030 (USD Million)
• Fig. 19 Carotid artery stents market, 2018 - 2030 (USD Million)
• Fig. 20 Renal artery stents market, 2018 - 2030 (USD Million)
• Fig. 21 Others market, 2018 - 2030 (USD Million)
• Fig. 22 Global PTA balloons market, 2018 - 2030 (USD Million)
• Fig. 23 Global catheters market, 2018 - 2030 (USD Million)
• Fig. 24 Global angiography catheters market, 2018 - 2030 (USD Million)
• Fig. 25 Global guiding catheters market, 2018 - 2030 (USD Million)
• Fig. 26 Global IVUS/OCT catheters market, 2018 - 2030 (USD Million)
• Fig. 27 Global endovascular aneurysm repair stent grafts market, 2018 - 2030 (USD Million)
• Fig. 28 Global thoracic endovascular aneurysm stent grafts market, 2018 - 2030 (USD Million)
• Fig. 29 Global abdominal endovascular aneurysm stent grafts market, 2018 - 2030 (USD Million)
• Fig. 30 Global plaque modification devices market, 2018 - 2030 (USD Million)
• Fig. 31 Global atherectomy devices market, 2018 - 2030 (USD Million)
• Fig. 32 Global thrombectomy devices market, 2018 - 2030 (USD Million)
• Fig. 33 Global peripheral accessories market, 2018 - 2030 (USD Million)
• Fig. 34 Global guidewires market, 2018 - 2030 (USD Million)
• Fig. 35 Global workhorse guidewires market, 2018 - 2030 (USD Million)
• Fig. 36 Global specialty guidewires market, 2018 - 2030 (USD Million)
• Fig. 37 Global extra support guidewires market, 2018 - 2030 (USD Million)
• Fig. 38 Global frontline finesse guidewires market, 2018 - 2030 (USD Million)
• Fig. 39 Global peripheral vascular closure devices market, 2018 - 2030 (USD Million)
• Fig. 40 Global balloon inflation devices market, 2018 - 2030 (USD Million)
• Fig. 41 Global introducer sheaths market, 2018 - 2030 (USD Million)
• Fig. 42 Global inferior vena cava filters market, 2018 - 2030 (USD Million)
• Fig. 43 Global permanent filters market, 2018 - 2030 (USD Million)
• Fig. 44 Global retrievable filters market, 2018 - 2030 (USD Million)
• Fig. 45 Global hemodynamic flow alteration devices market, 2018 - 2030 (USD Million)
• Fig. 46 Global chronic total occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 47 Global embolic protection devices market, 2018 - 2030 (USD Million)
• Fig. 48 Peripheral vascular devices market: Application dashboard
• Fig. 49 Peripheral vascular devices market Application movement analysis
• Fig. 50 Global peripheral arterial disease (PAD) market, 2018 - 2030 (USD Million)
• Fig. 51 Global aneurysms market, 2018 - 2030 (USD Million)
• Fig. 52 Global venous disease market, 2018 - 2030 (USD Million)
• Fig. 53 Global other vascular conditions market, 2018 - 2030 (USD Million)
• Fig. 54 Peripheral vascular devices market: End Use dashboard
• Fig. 55 Peripheral vascular devices market end use movement analysis
• Fig. 56 Global hospitals market, 2018 - 2030 (USD Million)
• Fig. 57 Global ambulatory surgical centers market, 2018 - 2030 (USD Million)
• Fig. 58 Global others market, 2018 - 2030 (USD Million)
• Fig. 59 Peripheral vascular devices market revenue, by region, 2024 & 2030, (USD Million)
• Fig. 60 Regional marketplace: Key takeaways
• Fig. 61 North America peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 62 U.S. peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 63 Canada peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 64 Mexico peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 65 Europe peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 66 UK peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 67 Germany peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 68 France peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 69 Italy peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 70 Spain peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 71 Denmark peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 72 Sweden peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 73 Norway peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 74 Asia Pacific peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 75 Japan peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 76 China peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 77 India peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 78 Australia peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 79 Thailand peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 80 South Korea peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 81 Latin America peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 82 Brazil peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 83 Argentina peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 84 MEA peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 85 South Africa peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 86 Saudi Arabia peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 87 UAE peripheral vascular devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 88 Kuwait peripheral vascular devices market, 2018 - 2030 (USD Million)
• Fig. 89 Heat map analysis
• Fig. 90 Overall market share analysis
• Fig. 91 Market share analysis by peripheral stents
• Fig. 92 Market share analysis by PTA balloons
• Fig. 93 Market share analysis by catheters
• Fig. 94 Market share analysis by endovascular aneurysm repair stent grafts
• Fig. 95 Market share analysis by plaque modification devices
• Fig. 96 Market share analysis by peripheral accessories
• Fig. 97 Market share analysis by inferior vena cava filters
• Fig. 98 Market share analysis by hemodynamic flow alteration devices
• Fig. 99 Strategy mapping

Peripheral Vascular Devices Market Growth & Trends:

The global peripheral vascular devices market size is expected to reach USD 14.8 billion by 2030, registering a CAGR of 5.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The factors driving market growth are the growing prevalence of peripheral arterial disease (pad), increasing clinical trials & studies, technological advancements, and government initiatives. Pharmaceutical companies and medical device manufacturers are increasingly funding clinical trials to explore innovative solutions for peripheral vascular disease PVD. This trend accelerates product development cycles and encourages collaboration between industry stakeholders and academic institutions.

As more studies are initiated, the data generated can significantly help improve these devices' performance and effectiveness. Moreover, regulatory support for increasing clinical trials is anticipated to boost these initiatives, thereby enhancing the development of advanced solutions in the market. For instance, in June 2024, AVS received an Investigational Device Exemption (IDE) from the FDA to conduct a clinical trial for its Pulsatile Intravascular Lithotripsy (PIL) system. The trial will assess the safety and effectiveness of the PIL system in patients with peripheral artery disease. AVS plans to initiate the study across multiple sites, marking a significant step forward in developing less invasive treatment options for patients suffering from calcified vascular conditions. Such efforts by market players, coupled with the developing R&D environment, are expected to drive market growth over the forecast period.

Moreover, the evolving competitive landscape of the peripheral vascular devices market is leading to several initiatives by market players that significantly increase their offerings and availability of these advanced devices to the healthcare sector globally, such as partnerships, expansion, agreements, acquisitions, and others. For instance, in June 2024, Boston Scientific announced an agreement to acquire Silk Road Medical, Inc., specializing in innovative solutions for carotid artery disease. The acquisition, valued at approximately USD 1.1 billion, aims to enhance Boston Scientific's portfolio in vascular intervention and expand its presence in the growing carotid artery market. Such initiatives by the market players to increase their offers, coupled with the growing availability of these devices, are expected to drive market growth over the forecast period.

Peripheral Vascular Devices Market Report Highlights:

• Based on type, the peripheral stents segment held the largest share of nearly 21.7% in 2024. The rising government support in the form of funding and approvals is encouraging manufacturers to develop technologically advanced peripheral stents.
• Based on application, the peripheral arterial disease (PAD) segment held the largest share of nearly 45.3% in 2024. The rising prevalence of peripheral artery disease and government initiatives drive segment growth.
• Based on end-use, the hospitals segment held the largest share of nearly 64.4% in 2024. Hospitals are crucial in administering advanced medical procedures, including Percutaneous Transmural Arterial Bypass (PTAB).
• North America dominated the peripheral vascular devices with a share of 38.9% in 2024. The peripheral vascular devices market exhibits consistent growth owing to several factors, including the growing incidence of Peripheral Artery Disease (PAD), rising geriatric population, and rapid advancements in medical technology.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. End use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market outlook
• 2.2. Segment outlook
  • 2.2.1. Type outlook
  • 2.2.2. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Peripheral Vascular Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing prevalence of PAD
    • 3.2.1.2. Increasing clinical trials and studies
    • 3.2.1.3. Novel product launch
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of treatment and devices
    • 3.2.2.2. Product recalls
• 3.3. Peripheral Vascular Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Peripheral Vascular Devices Market: Type Estimates & Trend Analysis

• 4.1. Peripheral Vascular Devices Market: Type Dashboard
• 4.2. Peripheral Vascular Devices Market: Type Movement Analysis
• 4.3. Peripheral Vascular Devices Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Peripheral Stents
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.1. Iliac Artery Stents
      • 4.4.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.2. Femoral Artery Stents
      • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.3. Carotid Artery Stents
      • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.4. Renal Artery Stents
      • 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.5. Other Peripheral Stents
      • 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. PTA Balloons
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Catheters
  • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.1.1. Angiography Catheters
      • 4.6.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.1.2. Guiding Catheters
      • 4.6.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.1.3. IVUS/OCT Catheters
      • 4.6.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Endovascular Aneurysm Repair Stent Grafts
  • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.1.1. Thoracic Endovascular Aneurysm Stent Grafts
      • 4.7.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.1.2. Abdominal Endovascular Aneurysm Stent Grafts
      • 4.7.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Plaque Modification Devices
  • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.8.1.1. Atherectomy Devices
      • 4.8.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.8.1.2. Thrombectomy Devices
      • 4.8.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Peripheral Accessories
  • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.9.1.1. Guidewires
      • 4.9.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.9.1.1.2. Workhorse Guidewires
        • 4.9.1.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.9.1.1.3. Specialty Guidewires
        • 4.9.1.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.9.1.1.4. Extra Support Guidewires
        • 4.9.1.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.9.1.1.5. Frontline Finesse Guidewires
        • 4.9.1.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.9.1.2. Peripheral Vascular Closure Devices
      • 4.9.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.9.1.3. Balloon Inflation Devices
      • 4.9.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.9.1.4. Introducer Sheaths
      • 4.9.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.10. Inferior Vena Cava Filters
  • 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10.2. Permanent Filters
    • 4.10.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10.3. Retrievable Filters
    • 4.10.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.11. Hemodynamic Flow Alteration Devices
  • 4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.11.2. Chronic Total Occlusion Devices
    • 4.11.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.11.3. Embolic Protection Devices
    • 4.11.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Peripheral Vascular Devices Market: Application Estimates & Trend Analysis

• 5.1. Peripheral Vascular Devices Market: Application Dashboard
• 5.2. Peripheral Vascular Devices Market: Application Movement Analysis
• 5.3. Peripheral Vascular Devices Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Peripheral Arterial Disease (PAD)
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Aneurysms
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Venous Diseases
  • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Peripheral Vascular Devices Market: End Use Estimates & Trend Analysis

• 6.1. Peripheral Vascular Devices Market: End Use Dashboard
• 6.2. Peripheral Vascular Devices Market: End Use Movement Analysis
• 6.3. Peripheral Vascular Devices Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Ambulatory Surgical Centers
  • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Peripheral Vascular Devices Market: Regional Estimates & Trend Analysis by Country, Type , Application, End use and Region

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
• 7.3. North America
  • 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Regulatory framework/ reimbursement structure
    • 7.3.4.3. Competitive scenario
    • 7.3.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Norway
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.9. Denmark
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Regulatory framework/ reimbursement structure
    • 7.4.9.3. Competitive scenario
    • 7.4.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. Australia
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. South Korea
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework/ reimbursement structure
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. Mexico
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Argentina
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework/ reimbursement structure
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2023
  • 8.3.4. Abbott
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Koninklijke Philips N.V.
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Edward Lifesciences Corporation
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Medtronic
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Teleflex Incorporated
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Cook Group
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Cordis
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Boston Scientific Corporation
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. W. L. Gore & Associates, Inc.
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Biotronik
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. BD
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives
  • 8.3.15. Terumo Corporation
    • 8.3.15.1. Company overview
    • 8.3.15.2. Financial performance
    • 8.3.15.3. Product benchmarking
    • 8.3.15.4. Strategic initiatives